Bench to Bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system

Academic Emergency Medicine

Volumn 12, Issue 12, 2005, Pages 1227-1235

  Sikka, Rishi ^a   Magauran, Brendan ^a   Ulrich, Andrew ^a   Shannon, Michael ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cytochrome P450; Drug interactions

Indexed keywords

ALPRAZOLAM; ASTEMIZOLE; ATORVASTATIN; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CISAPRIDE; CLARITHROMYCIN; CODEINE; CYCLOSPORIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DIAZEPAM; DILTIAZEM; FLUOXETINE; LOSARTAN; MEVINOLIN; MIDAZOLAM; MORPHINE; NIFEDIPINE; PARACETAMOL; PAROXETINE; THEOPHYLLINE; UNIDERM; WARFARIN;

ATAXIA; BIOCHEMISTRY; BIOTRANSFORMATION; CATALYSIS; DEEP VEIN THROMBOSIS; DIZZINESS; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG SAFETY; ENDOPLASMIC RETICULUM; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRAIT; HUMAN; HYDROPHILICITY; LIVER FAILURE; METABOLISM; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEROTONIN SYNDROME; SOMNOLENCE;

EID: 27944433905     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2005.06.027     Document Type: Article

References (71)

1. Committee on the Quality of Health Care in America Institute of Medicine L.T. Kohn J.M. Corrigan M.S. Donaldson To err is human: building a safer health system 2000 National Academy Press Washington, DC
2. M.J. Ellenhorn, and F.A. Sternad Problems of drug interactions J Am Pharmacol Assoc NS6 1996 62 68
3. M. Gosney, and R. Tallis Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital Lancet 1 1984 564 567
4. E. Kinney Expert system detection of drug interactions: results in consecutive patients Comput Biomed Res 19 1986 462 467
5. M.R. Dambro, and M.A. Kallgren Drug interactions in a clinic using COSTAR Comput Biol Med 18 1988 31 38
6. A.F. Shinn, R.P. Shrewsbury, and K.W. Anderson Development of a computerized drug interaction database (MEDICOM) for use in a patient specific environment Drug Inf J 17 1983 205 210
7. S. Kanamura, and J. Watanabe Cell biology of cytochrome P-450 in the liver Int Rev Cytol 198 2000 109 152
8. D. Mansuy The great diversity of reactions catalyzed by cytochromes P450 Comp Biochem Physiol 121 1998 5 14
9. R.W. Estabrook The remarkable P450s: a historical overview of these versatile hemeprotein catalysts FASEB J 10 1996 202 204
10. J.A. Hasler, R. Estabrook, and M. Murray Human cytochromes P450 Mol Aspects Med 20 1999 1 137
11. D.R. Nelson, L. Koymans, and T. Kamataki P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature Pharmacogenetics 6 1996 1 42
12. D.A. Flockhart, and J.E. Tanus-Santo Implications of cytochrome P450 interactions when prescribing medication for hypertension Arch Intern Med 162 2002 405 412
13. K. Venkatakrishnan, L.L. von Moltke, and D.J. Greenblatt Human drug metabolism and the cytochromes P450: application and relevance of in vitro models J Clin Pharmacol 41 2001 1149 1179
14. F.P. Guengerich Cytochrome P450 3A4: regulation and role in drug metabolism Annu Rev Pharmacol Toxicol 39 1999 1 17
15. U.A. Meyers The molecular basis of genetic polymorphisms of drug metabolism J Pharm Pharmacol 46S 1994 409 415
16. J.H. Lin, and A.Y.H. Lu Inhibition and induction of cytochrome P450 and the clinical implications Clin Pharmacokinet 35 1998 361 390
17. M.F. Fromm, H.K. Kroemer, and M. Eichelbaum Impact of P450 genetic polymorphism on the first-pass extraction of cardiovascular and neuroactive drugs Adv Drug Deliv Rev 27 1997 171 199
18. Home page of the Human Cytochrome P450 (CYP) Allele Nomenclature Committee. Available at: http://www.imm.ki.se/CYPalleles. Accessed Jun 1, 2005.
19. J. Desmeules, M.P. Gascon, P. Dayer, and M. Magistris Impact of environmental and genetic factors on codeine analgesia Eur J Clin Pharmacol 41 1991 23 26
20. R.L. Roberts, E.J. Begg, P.R. Joyce, and M.A. Kennedy How the pharmacogenetics of cytochrome P450 enzymes may affect prescribing N Z Med J 115 2002 137 140
21. D.J. Steward, R.L. Haining, and K.R. Henne Genetic association between sensitivity to warfarin and expression of CYP2C9*3 Pharmacogenetics 7 1997 361 367
22. C.L. Smith, E.M. Hampton, and J.A. Pederson Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients Pharmacotherapy 14 1994 471 481
23. B. Lee, N. Benowitz, and P. Jacob Cigarette abstinence, nicotine gum, and theophylline disposition Ann Intern Med 106 1987 553 555
24. F.P. Guengerich, N.A. Hosea, and A. Parikh Twenty years of biochemistry of human P450s: Purification, expression, mechanism and relevance to drugs Drug Metab Dispos 26 1998 1175 1178
25. Y. Horsmans, J.P. Desager, and C. Harvengt Absence of CYP3A genetic polymorphism assessed by urinary excretion of 6 beta-hydroxycortisol in 102 healthy subjects on rifampicin Pharmacol Toxicol 71 1992 258 261
26. P. Periti, T. Mazzei, E. Mini, and A. Novelli Pharmacokinetic drug interactions of macrolides Clin Pharmacokinet 23 1992 106 131
27. G.K. Dresser, J.D. Spence, and D.G. Bailey Pharmacokinetic- pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition Clin Pharmacokinet 38 2000 41 57
28. D.K. Wysowski, and J. Bacsanyi Cisapride and fatal arrhythmia N Engl J Med 335 1996 290 291
29. J.F. Westphal Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin Br J Clin Pharmacol 50 2000 285 295
30. J.W. Grunden, and K.A. Fisher Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin Ann Pharmacother 31 1997 859 863
31. J.Z. Ayanian, C.S. Fuchs, and R.M. Stone Lovastatin and rhabdomyolysis Ann Intern Med 109 1988 682 683
32. G.K. Dresser, D.G. Bailey, and S.G. Carruthers Grapefruit juice: felodipine interaction in the elderly Clin Pharmacol Ther 68 2000 28 34
33. J.S. Markowitz, J.I. Donovan, and C.L. DeVane Effect of St. John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme JAMA 290 2003 1500 1504
34. E. Ernst St. John's wort supplements endanger the success of organ transplantation Arch Surg 137 2002 316 319
35. C.M. Masimirembwa, and J.A. Hasler Genetic polymorphism of drug metabolising enzymes in African populations: implications for the use of neuroleptics and antidepressants Brain Res Bull 44 1997 561 571
36. L. Bertilsson, Y.Q. Lou, and Y.L. Du Pronounced difference between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquine and s-mephenytoin Clin Pharmacol Ther 51 1992 388 397
37. E. Aklillu, I. Persson, L. Bertilsson, I. Johansson, F. Rodrigues, and M. Ingelman-Sundberg Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles J Pharmacol Exp Ther 278 1995 441 446
38. M.L. Dahl, I. Johansson, L. Bertilsson, M. Ingelman-Sundberg, and F. Sjoqvist Ultrarapid hydroxylation of debrisoquine in a Swedish population: analysis of the molecular genetic basis J Pharmacol Exp Ther 274 1995 516 520
39. K. Brosen Isozyme specific drug oxidation: genetic polymorphism and drug-drug interactions Nord J Psychiatry 47 1993 21 26
40. T.I. Edeki, H. He, and A.J. Wood Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction JAMA 274 1995 1611 1613
41. J. Fang, and J.W. Gorrod Metabolism, pharmacogenetics and metabolic drug-drug interactions of antipsychotic drugs Cell Mol Neurobiol 19 1999 491 510
42. B.A. Hamelin, A. Bouayad, and J. Methot Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity Clin Pharmacol Ther 67 2000 466 477
43. Y. Ishii, K. Nakamura, K. Tsutsumi, T. Kotegawa, S. Nakano, and K. Nakatsuka Drug interaction between cimetidine and timolol ophthalmic solution: effect on heart rate and intraocular pressure in healthy Japanese volunteers J Clin Pharmacol 40 2000 193 199
44. D. Taylor, and M. Lader Cytochromes and psychotropic drug interactions Br J Psychiatry 168 1996 529 532
45. A. Harvey, and M. Burke Comment on the serotonin syndrome associated with paroxetine, an over-the counter cold remedy, and vascular disease Am J Emerg Med 13 1995 605 606
46. B. Skop, J. Finkelstein, T. Mareth, M.R. Magoon, and T.M. Brown The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease Am J Emerg Med 12 1994 642 644
47. M. Romkes, M.B. Faletto, J.A. Blaisdell, J.L. Raucy, and J.A. Goldstein Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450 IIC subfamily Biochemistry 30 1991 3247 3255
48. J.O. Miners, and D.J. Birkett Cytochrome P4502C9: an enzyme of major importance in drug metabolism Br J Clin Pharmacol 45 1998 525 538
49. H. Ninomiya, K. Mamiya, S. Matsuo, I. Ieiri, S. Higuchi, and N. Tashiro Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication Ther Drug Monit 22 2000 230 232
50. R.A. O'Reilly The stereoselective interaction of warfarin and metronidazole in man N Engl J Med 295 1976 354 357
51. D.J. Black, K.L. Kunze, and L.C. Wienkers Warfarin-fluconazole: a metabolically based drug interaction: in vivo studies Drug Metab Dispos 24 1996 422 428
52. L.A. Dent, and M.W. Orrock Warfarin-fluoxetine and diazepam-fluoxetine interaction Pharmacotherapy 1 1997 170 172
53. E.J. Allison Jr., T.J. McKinney, and J.N. Langenberg Spinal epidural haematoma as a result of warfarin/fluconazole drug interaction Eur J Emerg Med 9 2002 175 177
54. I. Niopas, S. Toon, L. Aarons, and M. Rowland The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans Eur J Clin Pharmacol 55 1999 399 404
55. J.A. Goldstein Clinical relevance of genetic polymorphisms in the human CYP2C subfamily Br J Clin Pharmacol 52 2001 349 355
56. C.R. Kumana, I.J. Lauder, M. Chan, W. Ko, and H.J. Lin Differences in diazepam pharmacokinetics in Chinese and white Caucasians - relation to body lipid stores Eur J Clin Pharmacol 32 1987 211 215
57. T. Furuta, K. Ohashi, and T. Kamata Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer Ann Intern Med 129 1998 1027 1130
58. K.E. Thummel, J.T. Slattery, and H. Ro Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults Clin Pharmacol Ther 67 2000 591 599
59. S.A. Jewell, D. DiMonte, A. Gentile, A. Guglielmi, E. Altomare, and O. Albano Decreased hepatic glutathione in chronic alcoholic patients J Hepatol 3 1986 1 6
60. R.C. Dart, E.K. Kuffner, and B.H. Rumack Treatment of pain or fever with paracetamol (acetaminophen) in the alcohol patient: a systematic review Am J Ther 7 2000 123 134
61. E.K. Kuffner, R.C. Dart, G. Bogdan, R.E. Hill, E. Casper, and L. Darton Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial Arch Intern Med 161 2001 2247 2252
62. M.T. Landi, R. Sinha, N.P. Lang, and F.F. Kadlubar Human cytochrome P4501A2 IARC Sci Publ 148 1999 173 195
63. L. Gervot, B. Rochat, and J.C. Gautier Human CYP2B6 expression, inducibility and catalytic activities Pharmacogenetics 9 1999 295 306
64. L.M. Hesse, K. Venkatakrishnan, and M.H. Court CYP2B6 mediates the in vitro hydroxylation of bupropion potential drug interactions with other antidepressants Drug Metab Dispos 28 2000 1176 1183
65. S. Palovaara, O. Pelkonen, J. Uusitalo, S. Lundgren, and K. Laine Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation Clin Pharmacol 74 2003 326 333
66. Drug interactions: defining genetic influences on pharmacologic responses. Available at: http://medicine.iupui.edu/flockhart. Accessed Aug 11, 2004.
67. The cytochrome p-450 enzyme system. Available at: http://www.edhayes.com/ startp450.html. Accessed Aug 11, 2004.
68. Mental Health Connections. Available at: http//www.mhc.com/cytochromes/ index.html. Accessed Aug 11, 2004.
69. FDA News. Available at: http://www.fda.gov/bbs/topics/news/2004/new01149. html. Accessed Jun 1, 2005.
70. K.E. Bizovi, B.E. Beckley, and M.C. McDade The effect of computer-assisted prescription writing on emergency department prescription errors Acad Emerg Med 9 2002 1168 1175
71. M.I. Langdorf, J.C. Fox, R.S. Marwah, B.J. Montague, and M.M. Hart Physician versus computer knowledge of potential drug interactions in the emergency department Acad Emerg Med 7 2000 1321 1329